Included were DNMT3A R882 and NPM1 W288, which occur in 14.9 and 25.6 % of acute myeloid leukemia (LAML) patients, respectively and have been shown important in LAML oncogenesis [35]. Here, DNMT3A is linked to acute myeloid leukemia.